Antidiabetic Drugs
Definition
Antidiabetics are medications used to treat diabetes mellitus in humans. These drugs lower blood sugar levels through various mechanisms of action. Accidental ingestion by dogs and cats can lead to severe intoxication symptoms, with the severity varying depending on the drug class, the amount ingested, and individual animal factors.
Antidiabetics are divided into different classes, which have different toxicity profiles:
Sulfonylureas (such as glipizide, glibenclamide, glimepiride) stimulate insulin release from the pancreas and represent the most dangerous group for pets, as they can cause severe and prolonged hypoglycemia.
Biguanides (mainly metformin) reduce glucose production in the liver and increase insulin sensitivity without directly increasing insulin secretion. They primarily cause gastrointestinal symptoms and, in severe cases, lactic acidosis.
SGLT2 inhibitors (such as empagliflozin, dapagliflozin) promote the excretion of glucose via the kidneys and can lead to electrolyte imbalances and metabolic disorders.
GLP-1 receptor agonists (such as exenatide, liraglutide) enhance glucose-dependent insulin secretion and inhibit glucagon release, which can lead to hypoglycemia.
DPP-4 inhibitors (such as sitagliptin, saxagliptin) prolong the effect of endogenous incretins and have a lower toxicity potential.
Thiazolidinediones (such as pioglitazone) increase insulin sensitivity and have a moderate toxicity potential.
Insulins and insulin analogs lead to rapid and potentially life-threatening hypoglycemia if incorrectly dosed.
The most important facts at a glance
Antidiabetic intoxications represent a medical emergency in small animal medicine. The various drug classes – sulfonylureas, biguanides, SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, thiazolidinediones, and insulins – exhibit different toxicity profiles and require specific therapeutic approaches.
The most common cause of such intoxications is the accidental ingestion of human medications by pets. Small dog breeds and cats are particularly at risk due to their lower body weight.
Clinical symptoms vary depending on the drug class. While sulfonylureas and insulins primarily lead to severe hypoglycemia with neurological symptoms, metformin intoxications mainly cause gastrointestinal complaints and potentially lactic acidosis.
Diagnosis is based on medical history, clinical symptoms, and the detection of hypoglycemia. Other causes of low blood sugar levels must be ruled out as differential diagnoses.
Therapy includes decontamination measures, glucose supplementation, and symptomatic therapy. In severe intoxications, intensive care monitoring with regular blood glucose checks is essential.
The prognosis is favorable in most cases with early detection and adequate therapy. Long-term consequences are rare, but neurological deficits can occur in severe hypoglycemic episodes.
Preventive measures such as the safe storage of medications and educating pet owners about potential dangers are crucial to minimize the risk of such poisonings.
Causes, development and progression
Various oral antidiabetics are used in human medicine. Their effect is based on various mechanisms.
- Increase in insulin sensitivity
- Increase in insulin secretion (direct/indirect)
- Increased sugar excretion
- Reduced sugar absorption/production
In humans, only 50-60% of the ingested amount is absorbed from the intestine, and absorption is completed after approximately 6 hours.
Elimination occurs via the kidneys.
The mean elimination half-life from plasma is between 1.5 and 4.5 hours, and correspondingly longer with impaired kidney function. With intact kidneys, 90% of elimination is completed after 24 hours.
The most common cause of antidiabetic intoxications in pets is the accidental ingestion of medications intended for human use. The risk is particularly high in households where diabetics live. Typical scenarios include:
Dropped tablets picked up by curious pets. Dogs, in particular, often exhibit indiscriminate eating behavior and can swallow several tablets at once.
Unsecured medication packaging that is chewed or bitten through by animals. Blister packs or pill containers, in particular, can be attractive to playful animals.
Improper disposal of medications in household waste accessible to animals.
Medication errors by pet owners who administer their own diabetes medications to their pets without veterinary instruction.
Confusion between human and veterinary medications in animals that actually suffer from and are being treated for diabetes.
The risk of intoxication is influenced by various factors. Small dog breeds and cats are particularly at risk due to their lower body weight, as even small amounts of active ingredients can lead to toxic concentrations. Animals with impaired kidney or liver function have an increased risk of severe intoxication symptoms, as the elimination of active ingredients may be delayed.
Mechanism of action
Metformin inhibits gluconeogenesis in the liver and increases the insulin sensitivity of cells.
However, it does not increase insulin secretion from the pancreas, so hypoglycemia is not expected with metformin intoxications. Nevertheless, signs of intoxications can occur.
The American Society for the Prevention of Cruelty to Animals (ASPCA) Animal Poison Control Center (APCC) indicates that metformin intoxications are reported, especially in dogs, but also in cats.
In human medicine, metformin reduces the formation of glucose from lactate in the liver. With prolonged use, this can lead to lactic acidosis. If kidney function is significantly impaired at the same time, the risk of life-threatening intoxication increases.
No information is available for animals.
In cats, the oral antidiabetic glipizide causes a drop in blood sugar levels in approximately 30% of cases.
Antidiabetics are used in humans to treat diabetes mellitus. Two substance classes are particularly relevant for accidental ingestion by animals:
1. Insulin (mostly human insulin)
Mechanism of Action:
- Stimulates glucose uptake into muscle, liver, and fat cells
- Significantly lowers blood sugar levels, → with overdose: severe hypoglycemia
Toxic Effect:
- Hypoglycemia: neurological symptoms (disorientation, ataxia, tremors, Seizures, unconsciousness)
- Complication: hypoglycemic coma → potentially fatal
Note: Ingestion of entire insulin pens or multiple units by dogs is particularly dangerous.
2. Oral Antidiabetic Drugs: Sulfonylureas (E.G., Glibenclamide, Glipizide)
Mechanism of Action:
- Stimulate insulin release from pancreatic beta cells independently of blood sugar levels
- Toxic effect: pronounced hypoglycemia due to uncontrolled insulin secretion
Effects:
- First symptoms within 1–3 hours after ingestion
- Tremors, lethargy, Muscle twitching, Seizures
- Life-threatening coma if left untreated
Summary
| Substance class | Mechanism of action in intoxication |
| SSRIs | Overstimulation of serotonergic synapses → Serotonin syndrome |
| TCAs | Multi-receptor effect (serotonergic, adrenergic, anticholinergic, cardiotoxic) → neurological and cardiac symptoms |
| SNRIs | Serotonergic and noradrenergic overstimulation → Hypertension, Seizures |
| MAO inhibitors | Increased effect of serotonin, norepinephrine, dopamine → Seizures, hypertension |
| Insulin | Uncontrolled glucose uptake → severe hypoglycemia |
| Sulfonylureas | Excessive insulin release → hypoglycemia with neurological deficits |
Symptoms of intoxication
Signs of intoxication from metformin ingestion in dogs and cats are generally mild and primarily affect the gastrointestinal tract.
Intoxications in cats due to glipizide can be significantly more severe due to the possible drop in blood sugar.
- severe Vomiting
- Diarrhea
- Lethargy
- Hypothermia
- Hypotension
- pale mucous membranes
- tremor in the hind limbs.
The clinical signs of antidiabetic intoxication vary depending on the drug class, the dose ingested, and the time since ingestion. The main symptomatology results from the blood sugar-lowering effect of these medications.
In sulfonylurea poisonings, the following symptoms typically occur:
- First signs of hypoglycemia such as weakness, lethargy, and ataxia can appear as early as 30 minutes to 1 hour after ingestion
- Progressive neurological symptoms such as disorientation, Behavioral changes, and Convulsions
- Cardiovascular symptoms such as tachycardia, later bradycardia and hypotension
- Hypothermia
- In severe cases, coma and Death
In metformin intoxications, gastrointestinal symptoms are prominent:
- Anorexia and Nausea
- Vomiting and diarrhea
- Dehydration
- In severe intoxications, lactic acidosis can develop, characterized by tachypnea, tachycardia, and increasing weakness
- Unlike other antidiabetics, metformin rarely causes hypoglycemia
SGLT2 inhibitors can cause the following symptoms:
- Polyuria and polydipsia
- Electrolyte imbalances
- Dehydration
- Metabolic acidosis
In insulin intoxications, rapid and severe hypoglycemia occurs:
- Rapid onset of weakness and ataxia
- Muscle tremors
- Behavioral changes up to Aggressiveness
- Convulsions
- Impaired consciousness up to coma
Especially in cats, the symptomatology can vary, as they sometimes react differently to certain active ingredients than dogs. In glipizide intoxications in cats, in addition to typical hypoglycemia symptoms, hind limb tremors, pale mucous membranes, and severe Vomiting have been observed.
The severity of symptoms correlates with the extent of the blood sugar drop. Neurological symptoms usually occur at blood sugar levels below 3 mmol/l (54 mg/dl), while values below 2 mmol/l (36 mg/dl) can be life-threatening.
Diagnosis
The diagnosis of antidiabetic intoxication is based on the medical history, clinical symptoms, and laboratory diagnostic examinations. Early and precise diagnosis is crucial for initiating adequate therapy.
Anamnestically, information about possible access to antidiabetics or observed ingestion of such medications is of great importance. Pet owners should, if possible, bring the medication packaging to the veterinarian to identify the active ingredient and dosage.
The clinical examination focuses on vital parameters and neurological status. Symptoms typical of hypoglycemia, such as weakness, ataxia, altered consciousness, or Convulsions, confirm the suspicion.
Laboratory diagnostics focus on blood glucose measurement. A significantly lowered blood glucose value (<3 mmol/l or <54 mg/dl) with a corresponding medical history and symptomatology is highly suspicious of antidiabetic intoxication. Blood glucose measurement should be performed repeatedly to document the course. Other important laboratory parameters include:
- Complete blood count and clinical chemistry for assessing organ function
- electrolytes (especially potassium)
- Acid-base status and lactate levels (especially in metformin poisonings)
- Kidney values (urea, creatinine) for assessing elimination capacity
In cases of unclear medical history, toxicological detection of antidiabetics in blood or urine can be helpful, but is often not available in a timely manner in practice.
Other causes of hypoglycemia must be ruled out as differential diagnoses:
- Insulinoma (neuroendocrine tumor of the pancreas)
- Hepatic diseases with impaired gluconeogenesis
- Hypoadrenocorticism (Addison’s Disease)
- Sepsis
- Poisonings with other substances (e.g., xylitol)
- Starvation ketonemia in young animals
Distinguishing between antidiabetic intoxication and an insulinoma can be difficult, although intoxication typically presents with a clear medical history and hypoglycemia does not recur after adequate therapy.
Therapeutic principles
Since no direct antidote is available for oral antidiabetics, the best therapy for metformin or glipizide intoxication is careful decontamination.
If metformin was ingested less than 2 hours ago, inducing Vomiting for decontamination is the method of choice. Activated charcoal should also be administered at a later time.
Otherwise, the therapy is symptomatic.
Special attention must be paid to cardiovascular function, kidney function, and water-electrolyte and acid-base balance.
Blood sugar should be optimized and monitored with appropriate infusion solutions, and lactate levels should also be monitored as a precaution. This applies particularly to metformin ingestion of >200 mg/kg body weight.
The use of lactate-containing infusion solutions should be avoided.
Gastrointestinal complaints must be treated.
Supplements
The therapy of antidiabetic intoxications requires a rapid and targeted approach. The therapy depends on the active ingredient, the amount ingested, the time of ingestion, and the clinical condition of the animal.
In cases of recent ingestion (less than 2–4 hours), decontamination is paramount:
- Inducing Vomiting with apomorphine (0.04 mg/kg IV or 0.08 mg/kg IM/SC in dogs) or xylazine (0.44 mg/kg IM in cats), provided the animal is conscious and neurologically stable
- Administration of activated charcoal (1–4 g/kg oral) to reduce further absorption
- For sulfonylurea intoxications, repeated administration of activated charcoal every 4–6 hours may be useful to interrupt the enterohepatic circulation
The mainstay of therapy for hypoglycemic patients is glucose supplementation:
- In conscious animals, initial oral glucose administration (honey, dextrose) can be given
- In more severely affected animals, intravenous glucose administration is indicated: bolus with 0.5-1 ml/kg of a 50% glucose solution, followed by a continuous infusion with 2.5-5% glucose solution
- The infusion rate is adjusted based on regular blood sugar monitoring (every 1–2 hours), with the goal of maintaining blood sugar above 3.5 mmol/L (63 mg/dL)
- In sulfonylurea intoxications, hypoglycemia can persist for 24–72 hours, requiring correspondingly long infusion therapy
Adjuvant therapy measures include:
- Glucagon (0.03-0.1 mg/kg IM or SC) can be used for severe hypoglycemia, but often has only a temporary effect
- Octreotide (1–5 μg/kg SC every 8–12 hours) can inhibit insulin secretion in sulfonylurea intoxications and is particularly indicated for therapy-resistant hypoglycemia
- Dexamethasone (0.1-0.2 mg/kg IV) can promote gluconeogenesis and reduce peripheral glucose utilization
In metformin poisonings, the treatment of lactic acidosis is paramount:
- Aggressive fluid therapy with isotonic saline solution
- Bicarbonate administration for severe metabolic acidosis (pH <7.1)
- Monitoring of kidney function and electrolytes
- In severe cases, hemodialysis or hemofiltration may be required
Intensive care monitoring includes:
- Continuous or regular blood sugar measurements
- ECG monitoring in case of cardiovascular involvement
- Monitoring of body temperature and oxygen saturation
- Monitoring of acid-base balance and electrolytes
In cases of Convulsions, anticonvulsive therapy with diazepam (0.5-1 mg/kg IV) or phenobarbital (2–4 mg/kg IV) is indicated.
Prognosis & follow-up care
The prognosis for antidiabetic intoxications largely depends on several factors: the specific drug class, the dose ingested, the time of therapy initiation, and the animal’s individual health status before the intoxication.
With early detection and adequate therapy, the prognosis for most animals with antidiabetic intoxications is favorable. Metformin intoxications, in particular, have a good prognosis with timely therapy, as they rarely lead to severe hypoglycemia. Gastrointestinal symptoms usually subside within 24–48 hours.
Sulfonylurea intoxications may require a more cautious prognosis, as the hypoglycemic effect can last up to 72 hours. However, with adequate glucose substitution and intensive monitoring, the prognosis is largely good here as well. The situation becomes critical if severe neurological symptoms such as persistent Convulsions or coma have already occurred before the start of therapy, as these can lead to irreversible brain damage.
The prognosis can be particularly unfavorable in metformin intoxications if severe lactic acidosis has already developed, especially in animals with pre-existing kidney dysfunction. In such cases, the mortality rate is significantly higher.
Aftercare following antidiabetic drug poisoning includes:
- Regular monitoring of blood sugar levels after discharge from inpatient treatment, especially for poisonings with long-acting sulfonylureas
- Monitoring of kidney and liver function, especially after metformin poisonings
- Neurological follow-up examinations for animals that have experienced severe hypoglycemic episodes with neurological symptoms
- Nutritional management with small, frequent meals in the first few days after discharge
- Advising pet owners on preventive measures to avoid future poisoning incidents
Long-term consequences are rare with timely therapy. In severe cases, however, permanent neurological deficits can occur, especially if hypoglycemia has led to longer-term cerebral ischemia. These can manifest as Behavioral changes, learning deficits, or focal neurological deficits.
Research outlook
Research in the field of antidiabetic intoxications in small animals is continuously evolving. Current studies focus on several promising areas:
New antidotes and therapy strategies are the focus of research. While traditional therapies are mainly based on glucose substitution and decontamination, more specific approaches are being investigated. For sulfonylurea intoxications, studies show that octreotide can effectively inhibit insulin secretion. Current research evaluates optimal dosages and application protocols for various animal species.
The development of point-of-care testing methods for the rapid detection of antidiabetics in blood or urine could significantly accelerate diagnosis. Such tests would offer great clinical benefit, especially in cases with an unclear medical history.
Veterinary-specific toxicity profiles of newer antidiabetics are being researched more intensively. With the introduction of new drug classes such as SGLT2 inhibitors or GLP-1 receptor agonists in human medicine, the risk of corresponding intoxications in pets also increases. Veterinary toxicological studies on these substances have been limited so far but are increasingly being conducted.
Long-term consequences of hypoglycemia-induced neurological damage and their management are also a focus of current research. Studies are investigating neuroprotective strategies that can be used during and after hypoglycemic episodes to minimize permanent brain damage.
The optimization of intensive care monitoring through continuous glucose monitoring systems, as already established in human medicine, is being adapted for veterinary use. These systems could improve therapy management in severe intoxication cases and reduce the risk of recurrent hypoglycemic episodes during therapy.
Epidemiological studies on the frequency and risk factors of antidiabetic intoxications in pets provide important data for preventive measures. In particular, the identification of particularly vulnerable populations (certain breeds, age groups, or behavioral types) could enable more targeted Prevention strategies.
The development of safe storage systems for medications in households with pets is another research area with practical relevance for the Prevention of intoxication cases.
Frequently asked questions (FAQs)
- Which antidiabetic drugs are most dangerous for pets?
Sulfonylureas and insulins pose the highest risk, as they can cause severe and prolonged hypoglycemia. Even small amounts can be life-threatening for small dogs or cats. - How quickly do symptoms appear after antidiabetic drug ingestion?
Symptoms can appear at different rates depending on the active ingredient. With insulins, first signs can be visible as early as 15–30 minutes, with sulfonylureas typically within 1–2 hours. Metformin intoxications usually show gastrointestinal symptoms only after several hours. - Can my pet recover on its own if it has ingested antidiabetic drugs?
This is possible with very small amounts and certain active ingredients like metformin. However, with sulfonylureas or insulins, a severe, potentially life-threatening course is to be expected without veterinary therapy, as hypoglycemia is often persistent. - How long does my pet need to be monitored after antidiabetic drug poisoning?
The monitoring duration depends on the active ingredient. For metformin, 24 hours are often sufficient, while for sulfonylureas, monitoring for 48–72 hours may be necessary, as the hypoglycemic effect can be delayed and long-lasting. - What immediate measures can I take if my pet has ingested antidiabetic drugs?
If the animal is awake and ingestion was recent (less than 30 minutes ago), you can induce Vomiting after consulting your veterinarian by phone. If symptoms are already present, you should seek veterinary attention immediately. If the animal is conscious, you can rub honey or sugar water on its gums to temporarily raise blood sugar. - Can antidiabetic drug poisonings cause permanent damage?
Yes, especially severe and prolonged hypoglycemic states can lead to permanent neurological damage. The brain is particularly sensitive to glucose deficiency, and prolonged hypoglycemic phases can lead to irreversible brain damage. - Are certain animal breeds or species more susceptible to antidiabetic drug poisonings?
Small dog breeds and cats are particularly at risk due to their low body weight, as even small amounts can lead to toxic concentrations. In addition, toy breeds and terriers often exhibit curious behavior, which increases the risk of ingestion. - How can I prevent antidiabetic drug poisonings in my pet?
Store medications in locked cabinets or containers that are inaccessible to animals. Do not take medications in the presence of your pets to minimize the risk of dropped tablets. Inform visitors who take antidiabetics about the dangers to your pets. - Can I give my own antidiabetic drugs to my diabetic dog or cat?
No, human medications should never be administered without veterinary instruction. Dosage, pharmacokinetics, and tolerability differ significantly between humans and animals. Diabetic pets require therapy specifically tailored to them. - How much does the treatment for antidiabetic drug poisoning cost?
Costs can vary considerably depending on the severity of the intoxication and the required therapy duration. Intensive care for several days with regular laboratory controls can cost between several hundred to over a thousand euros. Pet health insurance can be helpful in such cases.
Literature
- Heller, J. B. (2007). Metformin overdose in dogs and cats. VETERINARY MEDICINE-BONNER SPRINGS THEN EDWARDSVILLE-, 102(4), 231.
- Gwaltney-Brant, S. M. (2021). Antidiabetic drug toxicosis. In Veterinary Toxicology (pp. 515-522). Academic Press.
- Barrella, N., Eisenberg, B., & Simpson, S. N. (2017). Hypoglycemia and severe lactic acidosis in a dog following metformin exposure. Clinical Case Reports, 5(12), 2097-2103.
- Löwe G, Löwe O. Notfälle bei Hund und Katze – Ein tierärztlicher Ratgeber. 2. Auflage. Kreuztal: Kynos-Verlag. 2021; 208 p.